PPLPHARMA — Piramal Pharma Balance Sheet
0.000.00%
- IN₹283.81bn
- IN₹327.14bn
- IN₹81.71bn
Annual balance sheet for Piramal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 2,526 | 2,824 | 6,265 | 5,015 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 8,504 | 20,822 | 21,393 | 24,620 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 17,675 | 40,672 | 48,355 | 54,645 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 13,846 | 37,157 | 44,415 | 48,160 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 57,567 | 127,970 | 145,226 | 153,118 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 14,717 | 30,333 | 38,431 | 43,693 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 16,561 | 61,004 | 77,491 | 74,004 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 41,006 | 66,966 | 67,735 | 79,114 |
Total Liabilities & Shareholders' Equity | 57,567 | 127,970 | 145,226 | 153,118 |
Total Common Shares Outstanding |